Standout Papers

The NIMH-MATRICS Consensus Statement on Negative Symptoms 1997 2026 2006 2016 957
  1. The NIMH-MATRICS Consensus Statement on Negative Symptoms (2006)
    Bill Kirkpatrick, Wayne S. Fenton et al. Schizophrenia Bulletin
  2. The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis (1997)
    S.R. Marder, John M. Davis et al. The Journal of Clinical Psychiatry

Immediate Impact

8 from Science/Nature 74 standout
Sub-graph 1 of 20

Citing Papers

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Structural insights into the lipid and ligand regulation of serotonin receptors
2021 StandoutNature
7 intermediate papers

Works of S.R. Marder being referenced

P.2.108 Plasma lipids levels and glycemic control in long-term treatment with aripiprazole
2003
The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis
1997 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
S.R. Marder 2379 596 799 675 42 3.1k
Bernard A. Fischer 2062 726 675 528 38 2.8k
Katja Komossa 2903 433 488 719 26 4.1k
David G. Daniel 2684 514 470 661 90 3.8k
Jose Ma. J. Alvir 3002 352 716 1157 34 4.1k
G. M. Simpson 3592 348 578 779 41 4.3k
Gagan Fervaha 1907 729 559 533 94 2.7k
Maximilian Huhn 1973 333 396 566 36 2.8k
Ilaria Bonoldi 1886 434 677 581 57 2.9k
David Mayerhoff 2854 308 1134 1079 35 3.2k
Martina Hummer 2795 239 666 656 67 3.6k

All Works

Loading papers...

Rankless by CCL
2026